Publications by authors named "Simona Borstnar"

Claim this Profile
C
Corrigendum to "Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial" [The Breast 83 (2025) 104547].
Isabelle Demeestere, Samuel M Niman, Ann H Partridge, Daniela S Diego, Roswitha Kammler, Simona Borstnar

Breast· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial.
Isabelle Demeestere, Samuel M Niman, Ann H Partridge, Daniela S Diego, Roswitha Kammler, Simona Borstnar

Breast· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.
Fedro A Peccatori, Samuel M Niman, Ann H Partridge, Monica Ruggeri, Marco Colleoni, Simona Borstnar

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Sequencing in Metastatic HR+/HER2- Breast Cancer: A Delphi Consensus.
Lazar Popović, Simona Borštnar, Ivana Božović-Spasojević, Ana Cvetanović, Natalija Dedić Plavetić

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.
Hatem A Azim, Samuel M Niman, Ann H Partridge, Isabelle Demeestere, Monica Ruggeri, Simona Borstnar

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoids and triple-negative breast cancer treatment.
Luka Dobovišek, Simona Borštnar, Nataša Debeljak, Simona Kranjc Brezar

Front Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing HER2-low breast cancer management: enhancing diagnosis and treatment strategies.
Simona Borstnar, Ivana Bozovic-Spasojevic, Ana Cvetanovic, Natalija Dedic Plavetic, Assia Konsoulova

Radiol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptoms of Anxiety and Depression Among Slovenian Breast Cancer Survivors Post-Treatment During the COVID-19 Pandemic: A Cross-Sectional Study.
Špela Miroševič, Judith Prins, Nikola Bešić, Simona Borštnar, Andreja Cirila Škufca Smrdel

Zdr Varst· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an Early Individualized Integrated Rehabilitation Program versus Standard Rehabilitation Program for Smoking Cessation in 115 Smokers Among 467 Female Breast Cancer Patients 2019-2021 in Slovenia.
Romi Cencelj Arnez, Nikola Besic, Zlatka Mavric, Anamarija Mozetic, Tina Zagar, Simona Borstnar

Med Sci Monit· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients-a single institution experience.
Nina Pislar, Gorana Gasljevic, Maja Marolt Music, Simona Borstnar, Janez Zgajnar

World J Surg Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer.
Cvetka Grašič Kuhar, Simona Borštnar, Barbara Gazić, Erika Matos

Breast· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Ann H Partridge, Samuel M Niman, Monica Ruggeri, Fedro A Peccatori, Hatem A Azim, Simona Borstnar

N Engl J Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with a high level of unmet needs and their prevalence in the breast cancer survivors 1-5 years after post local treatment and (neo)adjuvant chemotherapy during the COVID-19: A cross-sectional study.
Špela Miroševič, Judith Prins, Simona Borštnar, Nikola Besić, Vesna Homar

Front Psychol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy.
Vlasta Hadalin, Nina Pislar, Simona Borstnar, Erika Matos, Anja Kovac

Clin Breast Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trial.
Simona Borstnar, Marketa Palacova, Aleksandra Łacko, Constanta Timcheva, Einav Nili Gal-Yam

Radiol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC.
Chris Twelves, Rupert Bartsch, Noa Efrat Ben-Baruch, Simona Borstnar, Luc Dirix

Clin Breast Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer.
Tsvetalina Tankova, Elżbieta Senkus, Maria Beloyartseva, Simona Borštnar, Doina Catrinoiu

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Michelino De Laurentiis, Simona Borstnar, Mario Campone, Ellen Warner, Javier Salvador Bofill

Breast Cancer Res Treat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer - results from a real-world setting.
Anja KovaČ, Erika Matos, Cvetka Grašič Kuhar, Marina Čakš, Tanja Ovčariček

Cancer Treat Res Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy.
Ann H Partridge, Samuel M Niman, Monica Ruggeri, Fedro A Peccatori, Hatem A Azim, Simona Borstnar

Breast· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Michelino De Laurentiis, Simona Borstnar, Mario Campone, Ellen Warner, Javier Salvador Bofill

Breast Cancer Res Treat· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial.
Elena López-Miranda, José Manuel Pérez-García, Serena Di Cosimo, Etienne Brain, Maja Ravnik

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment.
Luka Dobovišek, Fran Krstanović, Simona Borštnar, Nataša Debeljak

Cancers (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Cardiotoxicity after Adjuvant Concomitant Treatment with Radiotherapy and Trastuzumab in Patients with Breast Cancer.
Tanja Marinko, Simona Borstnar, Rok Blagus, Jure Dolenc, Cvetka Bilban-Jakopin

Radiol Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Treatment in Slovene Follicular Lymphoma Patients.
Tanja Južnič Šetina, Simona Borštnar, Barbara Jezeršek Novaković

Clin Lymphoma Myeloma Leuk· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis